Skip to main content

The Urethral Bulking Systems market to go Berserk with Covid-19, to Bounce back by mid-2021

 Urinary incontinence is a health issue experienced usually in women. In this condition the patient experience urine leakage due to pressure on urethra and bladder. Thus, frequent urination becomes a significant early symptom.  1 in 3 women at some point of time in their lives suffer from urinary incontinence. Aging increases the chances of urinary incontinence. Urethral incontinence is typically related with the economic burden and affect the quality of life. The treatment for urethral incontinence is usually surgery but with the growing advancement, the ureteral bulking systems has been proved as a better and advanced alternate to open surgery. These bulking systems help to resist the frequent urine flow. The bulking agents are injected in the periurethral wall and then solidifies to cover the wall of urethra, restricting the urine flow. Urethral bulking systems are usually made up of silicone beads, collagen, carbon particles, and polytetrafluoroethylene paste. Recently bulkamid, an injectable bulking agent has been proven effective for urethral incontinence.

The major driving factor for urethral bulking systems market is growing cases of urethral incontinence among women. Pregnancy, childbirth, hysterectomy, menopause are some of the major underlying physical problems that lead to urethral incontinence among women. Moreover, changing lifestyle is the major factor leading urethral incontinence. Also, rising awareness about disease related to urethral incontinence will lead the urethral bulking systems mark et to grow. The endlessly increasing adoption of injectable bulking systems is fueling the demand for urethral bulking systems market. However, lack of regulatory guideline for urethral bulking systems is anticipated to restrain the growth of the urethral bulking systems market. Also, the bulking systems are associated with side effects like urinary retention and urinary tract infection. These factors can hamper the growth of urethral bulking system market.

To remain ‘ahead’ of your competitors, request for a sample here@

https://www.persistencemarketresearch.com/samples/31450

The global Urethral bulking systems market is segmented on the basis of Disease type, Technique, and End User.

  • Urethral Bulking Systems market Segmentation by Disease Type-
    • Stress urinary Incontinence
    • Urgency Urinary Incontinence
    • Other Urinary Deficiency
  • Urethral Bulking Systems market Segmentation by Technique-
    • Endoscopic
    • Non- endoscopic
  • Urethral Bulking Systems market Segmentation by End User-
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others

The global urethral bulking systems market is segmented based on disease type, technique and end user. Among the disease type, Stress urinary incontinence (SUI) holds the largest share due to high prevalence of the disease in developed as well as developing nations. The SUI is more in U.S due to large geriatric population. The increased patient pool will help the doctors to focus more on treatment.  This will help the urethral bulking systems market to grow. Based on technique, endoscopic technique will continue to grow over the forecast period due to less side effects as the technique is minimal invasive. Also, the endoscopic technique is target specific, increasing the effectiveness of the treatment. Based on end user, hospitals capture the largest revenue share due to increasing urethral surgeries. Also growing number of hospital infrastructure in the developed will lead the growth of urethral bulking systems market.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/31450

Geographically, the global urethral bulking systems market is segmented into regions such as Latin America, Europe, North America, South Asia, East Asia Middle East & Africa and Oceania. North America is projected to emerge as prominent market in the global urethral bulking systems market due to advanced technology and increasing number of hospital infrastructure.  The urethral bulking systems market in the South Asia and East Asia is expected to grow substantially due to the increasing diagnostic centers dedicated to urethral bulking systems. Europe is expected to hold prominent share in the global urethral bulking systems market throughout the study period due to increasing cases of urethral incontinence.

Some of the major key players competing in the global urethral bulking systems market are CR Bard, Merz Aesthetics, Cogentix Medical, Q-Med, ASCENTX MEDICAL, INC., Coloplast Corp. Boston Scientific Corporation, AstraZeneca and few other urethral bulking systems manufacturers. The product launches are the strategy mostly adopted by major key players in the ureteral bulking systems market.

You Can Request for TOC Here @ https://www.persistencemarketresearch.com/toc/31450

Explore Extensive Coverage of PMR`s 

Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved Beg
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Top Market Insights

The Insulin Delivery Device Market To Show Constructive Disruption With US$ 14.09 Billion

Persistence Market Research Released New Market Report on “Global Market Study on Insulin Delivery Devices - Asia to Witness Highest Growth by 2020” the global insulin delivery devices market is estimated at USD 9,391.1 million in 2014 and is expected to grow at a  CAGR of 7%  from 2014 to 2020, to reach an estimated value of  USD 14,093.3 million in 2020 . The insulin delivery devices market is witnessing a significant growth due to the increasing prevalence of diabetes and rising obese endemic. In addition, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting in the growth of the global insulin delivery devices market. Get Going With Sample Of Insulin Delivery Device Market Report!  https://www.persistencemarketresearch.co/samples/2823 Some of the major players operating in the market: Abbott Laboratories. Novo Nordisk A/S. Eli Lilly and Company. Medtronic, Inc. Sanofi, Becton. Dickinson and Company...
Read Full Insight

The Bioinformatics Market To Grow Inadvertently

The Bioinformatics Market is bound to grow vigorously in the next 10 years. IoT has already made a beeline to the healthcare vertical. This has, in turn, enabled tracking of real-time locations of the apparatus and medical devices like scales, wheelchairs, defibrillators, or nebulizers along with remote monitoring. The entire healthcare vertical is expected to run on the IoT wave going forward.   The global  bioinformatics market  is exhibiting a  20.40% CAGR  from 2014 to 2020, according to a new market study recently released by Persistence Market Research. The market was calculated to be worth  US$4.1 bn  in 2014 and is estimated to reach  US$12.5 bn  by 2020, says PMR’s report, titled ‘ Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020 ’.   Get Going With Sample Of Bioinformatics Market Report!  https://www.persistencemarketresearch.com/samples/2778   The bioinformatics market is drive...
Read Full Insight

The Next 10 Years To Witness Formidable Growth Of Hospital Acquired Pneumonia Prevention Market (CAGR Of 4.7%) Between 2026

  The   Hospital Acquired Pneumonia Prevention Market Share   is estimated to be reaching   US$ 1,100 Million   at a   CAGR of 4.7%   from   2026 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. Over an eight-year period of assessment 2018-2026, the global market for hospital-acquired pneumonia prevention is poised to witness moderate growth, according to a recent research report on the global  hospital-acquired pneumonia prevention market . The report has been published by Persistence Market Research and is titled, “Hospital-Acquired Pneumonia Prevention Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026.” The  US$ 795 Mn  market is likely to exhibit a CAGR of 4.7%, reaching a value in exce...
Read Full Insight

The Next Decade To Sparkle With Acne Treatment Market Growing At The Rate Of 4.6% From 2025

  The   Acne Treatment Market Share   is estimated to be reaching   US$ 4,500 Million   at a   CAGR of 4.6%   from   2025 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. The average age of onset of acne has reduced from 14-15 years to 11-12 years due to changing demographics and social habits. Moreover, some of the misleading media content continue to encourage the habit of self-medication that often backfires, resulting in further complication. Over the past couple of years, demand for acne treatment drugs and medications has surged at a remarkable pace. After conducting an exclusive study, Persistence Market Research (PMR) identified that approximately 20% of the young population (aged below 13 years) suffer from moderate...
Read Full Insight

Sequential Advancements In Technology To Drive The Autogenous Vaccine For Aquaculture Market

  The   Autogenous Vaccine For Aquaculture Market Share  is expected to reach   US$ 11 Mn   between   2020 to 2030   at a   CAGR of 6% . Speedy development on the part of ICT does bring in new-fangled advantages like more autonomy to patients along with the promotion of interagency collaboration. As such, the ones with comorbidities and multidimensional problems would find themselves safe. This increased dependency is bound to drive the healthcare vertical going forward. Fish is a widely consumed food across the world. In 2019, 177.8 million metric tons of fish were produced globally. In spite of such huge production in aquaculture, bacterial disease is a major issue, and is causing multibillion-dollar losses annually. In developing countries, fish diseases often spread quickly between small-scale aquaculture farms. Rising prevalence of infectious diseases such as bacterial diseases, viral diseases, and parasitic and fungal diseases amongst fish s...
Read Full Insight

Opioids Market to Register CAGR 4.7% Increase in Revenue by 2021 End

  Persistence Market Research (PMR) delivers key insights on the Global   Opioids Market   in its latest report titled “Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period ”.The global opioids market is anticipated to exhibit a stable CAGR during the forecast period (2015-2021). By product type, the global opioids market is segmented into morphine, codeine, fentanyl, meperidine and methadone. Morphine segment was the largest contributor in overall opioids market, accounting for around 36% share in 2014. However, fentanyl segment is expected to register fastest CAGR of 4.7% during the forecast period. Synthetic opioids such as fentanyl, meperidine and methadone have lucrative growth opportunities in opioids market, owing to their potential application in opioid substitution treatment and fewer side effects as compared to natural opioids. Get Sample Copy of Report @  https://www.persis...
Read Full Insight

The Perfusion Bioreactors Market Is Expected To Grow On An Irrevocable Not At The Rate Of 7.5% Between 2021-2031

  The   Ischemic Optic Neuropathy Treatment Market Share  is expected to reach   US$ 187.7 Mn   at the rate of   3.7%   from   2021-2031 . With effective remote monitoring, the healthcare vertical is onto the awareness-building spree, so that patients could get benefited out of these services, telehealth, in particular. As such, several informative landing pages could be seen about the remote monitoring software. Ischemic optic neuropathy occurs because of a small vessel infraction of the optic nerve, and is a significant reason for impaired vision or blindness. Increasing utilization of newly approved intravitreal implants for the treatment of optic nerve disorders is expected to drive the market over the coming years. With developing awareness toward eye-associated inconveniences that give rise to impaired vision, diabetic patients and the geriatric population in developed nations are believed to have a proactive methodology for treatment-associ...
Read Full Insight

The Organic Mode Of Expansion To Dictate The Terms Of Growth For Phenylketonuria Treatment Market At The Rate Of CAGR 7% Between 2020 to 2030

  The   Phenylketonuria Treatment Market Share   is estimated to be reaching   US$ 565.8 Mn   at a   CAGR of 7%   from   2020 to 2030 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. Phenylketonuria (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for phenylketonuria as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the sympto...
Read Full Insight

Geographical Expansion To Catalyze The HPMC Capsules Market (US$ 120 Million) From 2025

  The   Global HPMC Capsules Market Share  is expected to reach   US$ 120 Million   at a CAGR of   10.9%   between   2025 . With “brand building” taking the center stage, the healthcare vertical would also be vying for brand building. In other words, increased visibility online would help the healthcare marketing service providers in making greater strides with regards to patient experience, right from drugs to treatment. HPMC capsules are strictly non-toxic and qualify to be Kosher and Halal-certified, which is why their popularity has grown in several parts of the world. Moreover, these capsules can significantly boost the body metabolism by improving absorption and digestion of protein, fat and carbohydrates. HPMC capsules find their application in the preparation of non-animal based medicines and cosmetics & nutraceuticals products. Persistence Market Research (PMR) recently conducted a study on the  global HPMC capsules market ...
Read Full Insight

The Peripheral Intravenous Catheter Market Is Expected To Grow On An Irrevocable Not At The Rate Of 7% Between 2019 to 2029

The  Global Peripheral Intravenous Catheter Market Share  is expected to reach  US$ 4.9 Billion  at a CAGR of  7%  between  2019 to 2029 . With “brand building” taking the center stage, the healthcare vertical would also be vying for brand building. In other words, increased visibility online would help the healthcare marketing service providers in making greater strides with regards to patient experience, right from drugs to treatment. Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at  US$ 4.9 Bn  in  2020 , and is expected to witness a healthy  CAGR of 7%  during the forecast period ( 2020 – 2030 ). Strategizi...
Read Full Insight